This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Intercontinental Hotels Group PLC | 9,124.0 | 4.0% |
| Hikma Pharmaceuticals PLC | 1,644.0 | 3.3% |
| Babcock International Group PLC | 1,273.0 | 3.2% |
| Natwest Group PLC | 520.4 | 3.0% |
| Kingfisher PLC | 301.0 | 2.8% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Metlen Energy & Metals PLC | 46.9 | -2.1% |
| Rio Tinto PLC | 4,831.5 | -1.7% |
| Coca-Cola Europacific Partners PLC | 6,620.0 | -1.2% |
| Spirax Group PLC | 6,795.0 | -1.2% |
| Bunzl PLC | 2,336.0 | -1.0% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 9,285 | 0.8% | 11.6% |
| DOW JONES INDUS. AVG | 46,247 | 0.7% | 9.3% |
| DAX INDEX | 23,739 | 0.9% | 21.9% |
| NIKKEI 225 | 44,935 | 0.9% | 12.9% |
| S&P/ASX 200 INDEX | 8,863 | 0.9% | 7.9% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 65.21 | -0.78% |
| Brent Crude (ICE) | USD/bbl. | 69.68 | -0.64% |
| Gold Spot | USD/t oz. | 3,815 | 1.5% |
| Copper (Comex) | USd/lb. | 480 | 0.7% |
Click graph to enlarge
The UK 100 is called to open +43 points this morning at 9,327. The UK 100 looks set to carry on where the index left off last week.
Stocks climbed Stateside on Friday,but still finished the week lower following the release of crucial inflation data. The Dow Jone advanced 299.97 points, or 0.65%, to close at 46,247.29. The S&P added 0.59% to close at 6,643.70, while the Nasdaq rose 0.44% to settle at 22,484.07. Friday’s rally snapped a three-day losing streak for the major indexes,but still ended the week down. The Nasdaq Composite and S&P 500 slid 0.7% and 0.3%, marking each index’s first losing week in four. The Dow shed 0.2%.
Asia markets have posted a mixed performance this morning, with the Nikkei 225 down 0.9% and the Hang Seng index up by 2%.
GSK today announced that chief executive Emma Walmsley is to step down from the board at the end of the year. She has been in charge of the drugs giant since April 2017. Chief commercial officer Luke Miels, who joined GSK in 2017, will take on the £1.375 million a year role from January.
UK
Carnival (CCL)
US
None
UK
A.G. Barr (BAG)*
Close Brothers Group (CBG)
US
Nike (NKE) AMC
ECB’s Cipollone speech
EU Business Climate
EU Consumer Confidence
ECB’s Nagel speech
ECB’s Schnabel speech
EU Economic Sentiment Indicator
Fed’s Waller speech
ECB’s Lane speech
BoE’s Ramsden speech
Fed’s Hammack speech
US Pending Home Sales
Fed’s Musalem speech
Fed’s Williams speech
Fed’s Bostic speech
UK 100 companies going ex-dividend on 2nd October 2025:
British American Tobacco
Weir Group
Smith & Nephew
F&C Investment Trust
UK 250 companies going ex-dividend on 2nd October 2025:
Kainos Group
Pantheon Infastructure
TP ICAP Group
Petershill Partners
Wickes Group
Hunting
Breedon Group
Morgan Sindall Group
Johnson Service Group
Bodycote
RIT Capital Partners
Law Debenture Group
Travis Perkins
Spectris
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.